Skip to main content

Advertisement

SpringerLink
Log in

The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

The study compares effects of the competitive and non-competitive NMDA receptor antagonists, CGP 40116 and MK-801 respectively, on the metabolism of dopamine and on the density of D-1 and D-2 dopaminergic receptors in the rat ventral tegmental area and substantia nigra. The effects of CGP 40116 were tested in a range of doses which either were devoid of or had locomotor- or stereotypy-stimulating effects. It was found that (1) CGP 40116 given in a dose of 5 mg/kg enhanced the locomotor activity of rats and evoked a stereotypy-like activity; doses of 1.25 and 2.5 mg/kg were devoid of such effects; (2) CGP 40116 (5 mg/kg) enhanced the concentrations of dopamine, DOPAC and HVA in the ventral tegmental area, whereas the lowest dose, 1.25 mg/kg was without effect; a dose of 2.5 mg/kg increased the concentration of dopamine only; the only effect of CGP 40116 (5 mg/kg) observed in substantia nigra, was an increase in dopamine concentration; its doses of 1.25 and 2.5 mg/kg were ineffective. (3) MK-801 (0.2 and 0.4 mg/kg) enhanced the concentrations of dopamine, DOPAC and HVA in both structures. A dose of 0.1 mg/kg increased the dopamine concentration only. The effects of MK-801 in substantia nigra were quantitatively weaker than those observed in ventral tegmental area. (4) Both CGP 40116 (5 mg/kg) and MK-801 (0.4 mg/kg) evolved alterations in the density of dopaminergic receptors. D-2 receptors, were up-regulated by MK-801 in ventral tegmental area and subregions of substantia nigra, i.e. pars compacta and pars reticulata, whereas CGP 40116 evoked similar effects in ventral tegmental area only. D-1 receptors in pars compacta and pars reticulata of substantia nigra were down-regulated after administration of either drug.

It is concluded that competitive NMDA receptor antagonists in doses which evoke hyperlocomotion and stereotypy-like activity, may have a substantial impact on the dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra, similar to that described for MK-801, a non-competitive NMDA receptor antagonist. The obtained results may suggest that CGP 40116 and, possibly, other competitive NMDA antagonists may have dopaminomimetic properties, and that their clinical potentials may be limited by the risk of evoking dopamine-dependent psychotomimetic and abusing effects, similar to those described for MK-801.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Biron D, Dauphin C, Di Paolo T (1992) Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors. Neuroendocrinology 55:468–476

    Google Scholar 

  • Bubser M, Keseberg U, Notz PK, Schmidt WJ (1992) Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol 229:75–82

    Google Scholar 

  • Carter CJ (1982) Topographical distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropharmacology 21:379–383

    Google Scholar 

  • Christie MJ, Bridge S, James LB, Beart PM (1985a) Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res 333:169–172

    Google Scholar 

  • Christie MJ, James LB, Beart PM (1985b) An excitant amino acid projection from the medial prefrontal cortex to the anterior part of nucleus accumbens in the rat. J Neurochem 45:477–482

    Google Scholar 

  • Dall'Olio R, Gandolfi O, Montanaro M, (1992) Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat. Psychopharmacology (Berl) 107:591–594

    Google Scholar 

  • Deutch AY, Tam SY, Freeman AS, Bowers MBJr, Roth RH (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Eur J Pharmacol 134:257–264

    Google Scholar 

  • Dragunow M, Faull RL (1990) MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett 113:144–150

    Google Scholar 

  • Fagg GE, Olpe HR, Pozza MF, Baud J, Steinmann M, Schmutz M, Portet C, Baumann P, Thedinga K, Bittiger H, et al (1990) CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity. Br J Pharmacol 99:791–797

    Google Scholar 

  • French ED, Ceci A, (1990) Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 119:159–162

    Google Scholar 

  • French ED, Ferkany J, Abreu M, Levenson S (1991) Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology 30:1039–1046

    Google Scholar 

  • French ED, Mura A, Wang T (1993) MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse 13:108–116

    Google Scholar 

  • Gandolfi O, Dall'Olio R (1993) Chronic treatment with MK-801 decreases D2 dopamine receptor function in rat striatum. Pharmacol Biochem Behav 44:683–687

    Google Scholar 

  • Gass P, Herdegen T, Bravo R, Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749–758

    Google Scholar 

  • Girault JA, Halpain S, Greengard P (1990) Excitatory amino acid antagonists and Parkinson's disease. Trends Neurosci. 13:325–327

    Google Scholar 

  • Goodwin P, Starr BS, Starr MS (1992) Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801. J Neural Transm Park Dis Dement Sect 4:15–26

    Google Scholar 

  • Halpain S, Girault JA, Greengard P (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343:369–372

    Google Scholar 

  • Hervé D, Trovero F, Blanc G, Thierry AM, Glowinski J, Tassin JP (1989) Nondopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of the rat striatum. J Neurosci 9:3699–3708

    Google Scholar 

  • Hiramatsu M, Cho AK, Nabeshima T (1989) Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine. Eur J Pharmacol 166:359–366

    Google Scholar 

  • Hondo H, Yonezawa Y, Nakahara T, Nakamura K, Hirano M, Uchimura H, Tashiro N (1994) Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res. 633:337–342

    Google Scholar 

  • Kabuto HI, Yokoi I, Mizukawa K, Mori A. (1989) Effects of an N-methyl-D-aspartate- receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique. Neurochem Res 14:1075–1081

    Google Scholar 

  • Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev. 18:75–113

    Google Scholar 

  • Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16:223–244

    Article  CAS  PubMed  Google Scholar 

  • Klockgether T, Turski L (1990) NMDA antagonists potentiate anti-parkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol 28:539–546

    Google Scholar 

  • Kobayashi K, Inoue O, (1993) An increase in the in vivo binding of SCH 23390 induced by MK-801 in the mouse striatum. Neuropharmacology 32:341–348

    Google Scholar 

  • Koek W, Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252:349–357

    Google Scholar 

  • Koek W, Woods JH, Winger GD (1988) MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969–974

    Google Scholar 

  • Liljequist S, Ossowska K, Grabowska Anden M, Anden NE (1991) Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 195:55–61

    Article  CAS  PubMed  Google Scholar 

  • Löscher W, Honack D (1991a) The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin IA receptors. J Pharmacol Exp Ther 257:1146–1153

    Google Scholar 

  • Löscher W, Honack D (1991b) Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther 256:432–440

    Google Scholar 

  • Löscher W, Honack D (1992) The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. Eur J Pharmacol 215:199–208

    Google Scholar 

  • Löscher W, Annies R, Honack D (1991) The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats. Neurosci. Lett 128:191–194

    Google Scholar 

  • Löscher W, Annies R, Honack D (1993) Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats. Eur. J Pharmacol 242:263–274

    Google Scholar 

  • Maj J, Rogóź Z, Skuza G (1991) Locomotor hyperactivity induced by MK-801 in rats. Pol J Pharmacol Pharm 43:449–458

    Google Scholar 

  • Mansbach RS, Geyer MA (1989) Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:299–308

    CAS  PubMed  Google Scholar 

  • Mansour A, Meador Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ, (1990) Localization of dopamine D2 receptor mRNA and Dl and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor auto radiographic analysis. J Neurosci 10:2587–2600

    Google Scholar 

  • Mansour A, Meador Woodruff JH, Zhou Q, Civelli O, Akil H, Watson SJ (1992) A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959–971

    Google Scholar 

  • Meador Woodruff JH, Mansour A, Healy DJ, Kuehn R, Zhou QY, Bunzow JR, Akil H, Civelli O, Watson SJ (1991) Comparison of the distributions of D1 and D2 dopamine receptor mRNAs in rat brain. Neuropsychopharmacology 5:231–242

    Google Scholar 

  • Meldrum BS (1985) Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68:113–122

    Google Scholar 

  • Micheletti G, Lannes B, Haby C, Borrelli E, Kempf E, Warter JM, Zwiller J (1992) Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum. Brain Res Mol Brain Res 14:363–368

    Google Scholar 

  • Morelli M, Di Chiara G (1990) MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. Eur J Pharmacol 182:611–612

    Google Scholar 

  • Morelli M, Fenu S, Pinna A, Di Chiara G (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1-and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260:402–408

    Google Scholar 

  • Olney JW (1989) Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry 26:505–525

    Google Scholar 

  • Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs [see comments]. Science 244:1360–1362

    CAS  PubMed  Google Scholar 

  • Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515–1518

    CAS  PubMed  Google Scholar 

  • Palkowits M, Brownstein MJ (1988) Maps and guide to microdissection of the rat brain. Elsevier, New York Amsderdam London

    Google Scholar 

  • Paul IA, Trullas R, Skolnick P, Nowak G (1992) Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists. Psychopharmacology (Berl) 106:285–287

    Google Scholar 

  • Pechnick RN, George R, Poland RE (1989) Characterization of the effects of the acute and repeated administration of MK-801 on the release of adrenocorticotropin corticosterone and prolactin in the rat. Eur J Pharmacol 164:257–263

    Google Scholar 

  • Porceddu ML, Giorgi O, Ongini E, Mele S, Biggio G (1986) 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine. Life Sci 39:321–328

    Google Scholar 

  • Pozza MF, Olpe HR, Brugger F, Fagg GE (1990) Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551. Eur J Pharmacol 182:91–100

    Google Scholar 

  • Qin ZH, Zhou LW, Weiss B (1994) D2 dopamine receptor messenger RNA is altered to a greater extent by blockade of glutamate receptors than by blockade of dopamine receptors. Neuroscience 60:97–114

    Google Scholar 

  • Rao TS, Kim HS, Lehmann J, Martin LL, Wood PL (1990) Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J Neurochem 54:1157–1162

    Google Scholar 

  • Rao TS, Contreras PC, Cler JA, Mick SJ, Dilworth VM, Iyengar S, Monahan JB, Wood PL (1991) Contrasting neurochemical interactions of tiletamine, a potent phencyclidine (PCP) receptor ligand, with the N-methyl-D-aspartate-coupled and -uncoupled PCP recognition sites. J Neurochem 56:890–897

    Google Scholar 

  • Rogawski MA (1992) The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report. Drugs 44:279–292

    Google Scholar 

  • Savasta M, Dubois A, Benavides J, Scatton B (1986a) Different neuronal location of SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat. Neurosci Lett 72:265–271

    Google Scholar 

  • Savasta M, Dubois A, Scatton B (1986b) Autoradiographic localization of Dl dopamine receptors in the rat brain with SCH 23390. Brain Res 375:291–301

    Google Scholar 

  • Schmutz M, Porter C, Jeker A, Klebs K, Vassout A, Allgeier H, Heckendorn R, Fagg GE, Olpe HR, van Riezen H (1990) The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents. Naunyn Schmiedeberg's Arch Pharmacol 342:61–66

    Google Scholar 

  • Sesack SR, Deutch AY, Roth RH, Bunney BS (1989) Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin J Comp Neurol 290:213–242

    Google Scholar 

  • Sharp FR, Butman M, Koistinaho J, Aardalen K, Nakki R, Massa SM, Swanson RA, Sagar SM (1994) Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels. Neuroscience 62:1079–1092

    Google Scholar 

  • Sveinbjornsdottir S, Sander JK, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D, Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165–174

    Google Scholar 

  • Svensson A, Pileblad E, Carlsson M (1991) A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice. J Neural Transm 85:117–129

    Google Scholar 

  • Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85–87

    Google Scholar 

  • Węzony K, Czyrak A (1994) The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effects of MK-801. Brain Res 657:351–356

    Google Scholar 

  • Węzony K, Gołembiowska K, Klimek V (1993a) MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res 625:333–336

    Google Scholar 

  • Węzony K, Klimek V, Gołembiowska K (1993b) MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D-1 receptors. Brain Res 622:325–329

    Google Scholar 

  • Węzony K, Gołembiowska K, Zazula M (1994) Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex in rats. Naunyn Schmiedeberg's Arch Pharmacol 350:555–562

    Google Scholar 

  • Willetts J, Balster RL, Leander JD (1990) The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423–428

    Google Scholar 

  • Wolf ME, Khansa MR (1991) Repeated administration of Mk-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164–168

    Google Scholar 

  • Wolf ME, White FJ, Hu XT (1993) Behavioural sensitization to MK-801 (dizocilpine): neurochemical and electropbysiological correlates in mesoaccumbal dopamine system. Behavioural Pharmacol 4:429–442

    Google Scholar 

  • Wolf ME, White FJ, Hu XT (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735–1745

    Google Scholar 

  • Wong EH, Knight AR, Woodruff GN (1988) [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. J Neurochem 50:274–281

    Google Scholar 

  • Zhang J, Chiodo LA, Freeman AS (1992) Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons. Brain Res 590:153–163

    Google Scholar 

  • Zhang J, Chiodo LA, Freeman AS (1993) Effects of phencyclidine, MK-801 and 1,3-di(2-tolyl)guanidine on non-dopaminergic midbrain neurons. Eur J Pharmacol 230:371–374

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pharmacology, Polish Academy of Sciences, 12 Smðna Street, 31-343, Kraków, Poland

    Krzysztof Węzony, Anna Czyrak, Marzena Mackowiak & Katarzyna Fijal

Authors
  1. Krzysztof Węzony
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Czyrak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marzena Mackowiak
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katarzyna Fijal
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Węzony, K., Czyrak, A., Mackowiak, M. et al. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 353, 517–527 (1996). https://doi.org/10.1007/BF00169171

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169171

Key words

Search

Navigation